Cell Therapy Technologies Market Report 2026

The cell therapy technologies market size has grown rapidly in recent years. It will grow from $5.67 billion in 2025 to $6.52 billion in 2026 at a compound annual growth rate (CAGR) of 15%. The growth in the historic period can be attributed to increasing clinical research in cell-based therapies, rising adoption of stem cell treatments, expansion of research cell banks, availability of advanced bioprocessing equipment, growth in translational medicine programs.

The cell therapy technologies market size is expected to see rapid growth in the next few years. It will grow to $11.35 billion in 2030 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to increasing commercialization of cell therapies, rising investments in regenerative medicine, expansion of point-of-care cell therapy systems, growing demand for automated manufacturing workflows, increasing regulatory focus on process consistency. Major trends in the forecast period include increasing adoption of closed-system cell processing platforms, rising use of automated cell culture systems, growing demand for scalable cell therapy manufacturing, expansion of process monitoring and quality control tools, enhanced focus on standardized cell handling.

The rising prevalence of cancer is anticipated to fuel the growth of the cell therapy technologies market over the forecast period. Cell therapy involves the use of living cells as therapeutic agents to treat diseases. In cancer treatment, cell therapy leverages the immune system’s natural capacity to identify and eliminate abnormal cells within the body. For instance, in January 2024, according to the American Cancer Society, a US-based nonprofit cancer advocacy organization, the number of cancer cases rose to 2,001,140 compared to 1,958,310 in 2023, representing an increase of 2.19%. Therefore, the growing number of cancer cases is expected to support the expansion of the cell therapy technologies market going forward.

Major companies operating in the cell therapy market are emphasizing technological innovations such as automated manufacturing platforms to enhance scalability, consistency, and efficiency in the production of cell-based therapies. Automated cell therapy technologies combine robotics, process monitoring, and closed-system manufacturing to optimize production workflows while ensuring cell quality and compliance with regulatory standards. For instance, in 2025, Limula, a US-based cell therapy company, introduced an automated cell therapy platform aimed at speeding up cell manufacturing, minimizing manual handling, and improving the consistency and safety of therapeutic cell products. The introduction of this platform represents an important step toward large-scale commercial production of cell therapies, enabling quicker transition from research to clinical use.

In October 2025, Bristol Myers Squibb, a US-based biopharmaceutical company, acquired Orbital for $1.5 billion. Through this acquisition, Bristol Myers Squibb seeks to broaden its cell therapy pipeline, accelerate the development of next-generation cellular therapies, reinforce its presence in the oncology and immunotherapy markets, and strengthen long-term growth prospects in advanced biopharmaceuticals. Orbital Therapeutics is a US-based cell therapy biotechnology company specializing in the development of innovative cell therapy platforms for the treatment of complex diseases.

Major companies operating in the cell therapy technologies market are Lonza Group AG, Thermo Fisher Scientific Inc, Merck KGaA, Terumo Corporation, Danaher Corporation, Fujifilm Holdings Corporation, Sartorius AG, Becton Dickinson and Company, Avantor Inc., Cellular Biomedicine Group, CORESTEM, Astellas Pharma Inc, Anterogen Co. Ltd, Arce Therapeutics, CARsgen Therapeutics, Co.Don AG, Neogene Therapeutics, GammaDelta Therapeutics Limited, SOTIO, Genestack, Novartis AG, Celgene Corporation, Gilead Sciences, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Amgen, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Next BioSciences, CryoSave, BioHeart, Stem Cell Technologies.

North America was the largest region in the cell therapy technologies market in 2025. Asia-Pacific is predicted to record the fastest growth over the forecast period. The regions covered in the cell therapy technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cell therapy technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the cell therapy technologies market by increasing costs of imported bioreactors, cell processing equipment, automated culture systems, software platforms, and sterile consumables. Life science companies in North America and Europe are most affected due to reliance on specialized imported equipment, while Asia-Pacific faces higher costs for technology integration. These tariffs are elevating production costs and slowing scale-up timelines. However, they are also encouraging localized manufacturing, regional automation development, and long-term investments in domestic cell therapy infrastructure.

The cell therapy technologies market research report is one of a series of new reports that provides cell therapy technologies market statistics, including cell therapy technologies industry global market size, regional shares, competitors with a cell therapy technologies market share, detailed cell therapy technologies market segments, market trends and opportunities, and any further data you may need to thrive in the cell therapy technologies industry. This cell therapy technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Cell therapy is a form of treatment in which living cells are administered into a patient’s body to treat specific diseases or disorders. This therapy aims to address medical conditions by modifying or replacing particular cell populations. In this approach, cells obtained from the patient or a donor are manipulated outside the body and then introduced back into the patient.

The main types of products in cell therapy technologies include consumables, equipment, and systems and software. Consumables are items designed to be used up or exhausted during routine use. These technologies are applied to various cell types, including T cells, stem cells, and other cells. The processes involved in cell therapy technologies include cell processing, cell preservation, distribution, handling, process monitoring, and quality control. Cell therapy technologies are utilized across sectors such as life science companies, research institutes, and cell banks.

The cell therapy market consists of sales of cell therapy technologies that are medicinal solutions used for developing and improving cell therapy, such as cell processing, cell banking, and point-of-care technologies. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.